ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 842

Is Rheumatoid Arthritis a Coronary Heart Disease Risk Equivalent, Similar to Diabetes?

Jie Zhang1, Shuo Yang2, Lang Chen3, Fenglong Xie4, Huifeng Yun5, Paul M. Muntner6, Emily Levitan6, Monica Safford7, Kenneth G. Saag8, Jasvinder A. Singh7 and Jeffrey R. Curtis7, 1Ryals Soph Bldg., Rm. 517b, Univ. of Alabama at Birmingham, Birmingham, AL, 2Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 5Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, 6Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 7University of Alabama at Birmingham, Birmingham, AL, 8Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, rheumatoid arthritis (RA) and risk assessment

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Session Title: Rheumatoid Arthritis - Clinical Aspects I: Cardiovascular Disease Risk

Session Type: Abstract Submissions (ACR)

Background/Purpose: Recently cholesterol treatment guidelines recommend that diabetes (DM) should be considered a CVD risk equivalent to a history of coronary heart disease (CHD). Despite the well-recognized increased CVD risk in rheumatoid arthritis (RA) patients, the guidelines do not recommend that RA should be considered a CHD risk equivalent. We compared the incidence of hospitalized acute myocardial infarction (MI) among patients with DM alone, RA alone, both conditions and neither of them.

 

Methods: Using a mix of private and public health plans claims data from 2006 to 2010 with medical and pharmacy coverage; we identified 4 mutually exclusive cohorts: patients with 1) RA and DM; 2) RA only; 3) DM only; 4) Neither RA nor DM.  Patients with prevalent CHD during a baseline period of ≥ 1 year were excluded. Acute MI was defined as ≥ 1 inpatient hospital claim with a discharge ICD-9 code in any position for 410.x (excluding 410.x2) and at least one overnight stay, unless the patient died. We compared the age- and gender-specific incidence rates (IRs) of acute MI across the four cohorts and calculated differences in IRs between select cohorts.

 

Results:  We identified 1,070,212 eligible participants in our study. MI IRs were highest among adults with both RA and DM, followed by those with DM alone, with RA alone, and lowest in those without either condition.  Findings were consistent for both sexes and across all age strata (Table). Among women 41 years of age or older, the absolute difference in IRs between the two cohorts peaked at 4.3 cases per 1,000 Person-Years (PYs) among those 71 or older. Among men, the peak difference (4.61 cases per 1,000 PYs) was observed among those 51-60 years of age. We found large increases in MI IR among RA patients if they were also diagnosed with DM, especially among women with the greatest difference (9.3 cases per 1,000 PYs) observed among women 51-60 years of age.

Conclusion: In this analysis, the incidence of MI was consistently lower in patients with RA alone than in those with DM alone, which does not support RA as a CHD risk equivalent. Our findings have important clinical implications in the treatment of hyperlipidemia for RA patients.


Table: Comparison of Age- and Gender-Specific MI Risk between Patients with RA, Diabetes (DM) and Both to Healthy Patients

 

Both DM and RA

DM Only

RA Only

Neither DM Nor RA

Risk Difference

Age group

# Person-Years

(PYs)

MI Incidence Rate (IR*)

PYs

MI IR*

PYs

MI IR*

PYs

MI IR*

DM Alone –

RA Alone

DM and RA –

RA Alone

Female

 

 

 

 

 

 

 

 

 

 

41-50

754

5.31

16453

3.95

6138

1.96

73179

0.85

1.99

3.35

51-60

1923

11.96

32431

6.08

10558

2.65

84338

1.64

3.43

9.31

61-70

3400

11.47

61620

8.10

18410

5.81

141474

3.13

2.29

5.66

71-85

4038

18.08

106349

15.95

25474

11.66

300340

8.24

4.29

6.42

Male

 

 

 

 

 

 

 

 

0

 

41-50

215

4.65

17393

4.37

1522

2.63

63340

1.60

1.74

2.02

51-60

459

4.36

28154

7.71

2583

3.10

70147

2.87

4.61

1.26

61-70

997

11.03

47776

10.09

4257

7.75

107472

4.96

2.34

3.28

71-85

928

20.48

54639

16.93

4898

13.68

159464

10.10

3.25

6.8

*Incidence rate, per 1,000 person-years

                                                                                                                                                                                                    

 


Disclosure:

J. Zhang,
None;

S. Yang,
None;

L. Chen,
None;

F. Xie,
None;

H. Yun,

Amgen,

2;

P. M. Muntner,

Amgen,

2,

Amgen,

5;

E. Levitan,

Amgen,

2;

M. Safford,

Amgen,

2,

diaDexus, Inc.,

5;

K. G. Saag,
None;

J. A. Singh,

Savient,

2,

Takeda,

2,

Degeneron,

5,

Allergan ,

5;

J. R. Curtis,

Roche, Genentech, UCB Pharma, Janssen, CORRONA, Amgen, Pfizer, BMS, Crescendo, AbbVie,

2,

Roche, Genentech, UCB Pharma, Janssen, CORRONA, Amgen, Pfizer, BMS, Crescendo, AbbVie,

5.

  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-rheumatoid-arthritis-a-coronary-heart-disease-risk-equivalent-similar-to-diabetes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.